In addition to promotion of adoptive T cell transfer, recent studies showed that conventional chemotherapeutic agents such as cisplatin and doxorubicin enhanced tumor cell sensitivity by CTL-mediated cancer immunotherapy through upregulation of CI-MPR on the tumor cell surface [25, 26, 37]. This evidence concerns the gene IGF2R and cancer.